Total Payments
$4,941
2024 Payments
$802.26
Companies
51
Transactions
227
Medicare Patients
2,792
Medicare Billing
$726,197
Payment Breakdown by Category
Food & Beverage$4,369 (88.4%)
Consulting$300.00 (6.1%)
Education$271.80 (5.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,369 | 217 | 88.4% |
| Consulting Fee | $300.00 | 2 | 6.1% |
| Education | $271.80 | 8 | 5.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $633.19 | 38 | $0 (2024) |
| Celgene Corporation | $310.05 | 16 | $0 (2024) |
| COMSORT, Inc | $300.00 | 2 | $0 (2017) |
| PFIZER INC. | $288.88 | 9 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $250.61 | 16 | $0 (2023) |
| GENZYME CORPORATION | $206.77 | 5 | $0 (2023) |
| Seattle Genetics, Inc. | $190.45 | 12 | $0 (2019) |
| Lilly USA, LLC | $176.73 | 10 | $0 (2023) |
| Daiichi Sankyo Inc. | $171.90 | 5 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $171.83 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $802.26 | 29 | Daiichi Sankyo Inc. ($124.77) |
| 2023 | $402.68 | 17 | BeiGene USA, Inc. ($81.36) |
| 2022 | $333.66 | 14 | Taiho Oncology, Inc. ($65.11) |
| 2021 | $302.39 | 15 | Merck Sharp & Dohme Corporation ($121.06) |
| 2020 | $188.54 | 10 | Merck Sharp & Dohme Corporation ($38.67) |
| 2019 | $444.42 | 24 | Merck Sharp & Dohme Corporation ($100.31) |
| 2018 | $1,308 | 64 | Merck Sharp & Dohme Corporation ($184.55) |
| 2017 | $1,159 | 54 | COMSORT, Inc ($300.00) |
All Payment Transactions
227 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $27.81 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological), TALVEY, DARZALEX | Food and Beverage | In-kind items and services | $35.15 | General |
| Category: Oncology | ||||||
| 11/26/2024 | PFIZER INC. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $25.28 | General |
| Category: Oncology | ||||||
| 11/21/2024 | PFIZER INC. | TIVDAK (Biological) | Food and Beverage | In-kind items and services | $35.88 | General |
| Category: Oncology | ||||||
| 11/19/2024 | SpringWorks Therapeutics, Inc. | OGSIVEO (Drug) | Food and Beverage | In-kind items and services | $42.05 | General |
| Category: DESMOID TUMORS | ||||||
| 11/06/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: ONCOLOGY | ||||||
| 10/08/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Oncology | ||||||
| 10/03/2024 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $30.60 | General |
| Category: Oncology | ||||||
| 09/12/2024 | SpringWorks Therapeutics, Inc. | OGSIVEO (Drug) | Food and Beverage | In-kind items and services | $39.90 | General |
| Category: DESMOID TUMORS | ||||||
| 09/05/2024 | Legend Biotech USA Inc. | — | Food and Beverage | In-kind items and services | $22.99 | General |
| 09/05/2024 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $7.18 | General |
| Category: HEMATOLOGY | ||||||
| 09/03/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $27.88 | General |
| Category: ONCOLOGY | ||||||
| 08/29/2024 | ARRAY BIOPHARMA INC | XALKORI (Drug), LORBRENA, BRAFTOVI | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: ONCOLOGY | ||||||
| 08/27/2024 | SERVIER PHARMACEUTICALS LLC | Tibsovo (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Oncology | ||||||
| 08/13/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: ONCOLOGY | ||||||
| 08/08/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: ONCOLOGY | ||||||
| 08/06/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: Oncology | ||||||
| 07/30/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: ONCOLOGY | ||||||
| 07/02/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: ONCOLOGY | ||||||
| 06/27/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $26.03 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 06/25/2024 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: CELLT | ||||||
| 06/11/2024 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 06/06/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: ONCOLOGY | ||||||
| 06/04/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $23.60 | General |
| Category: Hematology/Oncology | ||||||
| 03/26/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $29.83 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 567 | 46,906 | $586,311 | $191,930 |
| 2022 | 8 | 567 | 7,738 | $252,748 | $84,583 |
| 2021 | 10 | 669 | 12,417 | $364,828 | $147,647 |
| 2020 | 10 | 989 | 33,059 | $787,441 | $302,037 |
Total Patients
2,792
Total Services
100,120
Medicare Billing
$726,197
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 2023 | 12 | 37,800 | $302,400 | $89,522 | 29.6% |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 2023 | 16 | 4,480 | $89,600 | $27,198 | 30.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 12 | 1,260 | $37,800 | $22,424 | 59.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 128 | 194 | $56,260 | $19,771 | 35.1% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2023 | 13 | 1,540 | $32,340 | $8,373 | 25.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 61 | 107 | $21,400 | $7,896 | 36.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 96 | 556 | $16,124 | $4,231 | 26.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 96 | 540 | $4,815 | $4,127 | 85.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 21 | 21 | $11,508 | $3,719 | 32.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 45 | 264 | $10,032 | $3,179 | 31.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 67 | 144 | $4,032 | $1,490 | 37.0% |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 2022 | 17 | 5,780 | $115,600 | $36,887 | 31.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 152 | 267 | $77,430 | $27,051 | 34.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 48 | 76 | $15,200 | $5,952 | 39.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 105 | 561 | $16,269 | $4,302 | 26.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 34 | 309 | $11,742 | $3,890 | 33.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 16 | 16 | $8,768 | $3,013 | 34.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 91 | 178 | $4,984 | $1,855 | 37.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 104 | 551 | $2,755 | $1,632 | 59.2% |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 2021 | 22 | 7,740 | $154,800 | $52,948 | 34.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 18 | 2,520 | $58,320 | $41,129 | 70.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 151 | 266 | $77,140 | $27,945 | 36.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 64 | 127 | $25,400 | $9,112 | 35.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 122 | 626 | $18,154 | $4,864 | 26.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 49 | 272 | $10,336 | $3,381 | 32.7% |
About Dr. Warren Paroly, MD
Dr. Warren Paroly, MD is a Hematology & Oncology healthcare provider based in Oceanside, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/21/2007. The National Provider Identifier (NPI) number assigned to this provider is 1306981527.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Warren Paroly, MD has received a total of $4,941 in payments from pharmaceutical and medical device companies, with $802.26 received in 2024. These payments were reported across 227 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($4,369).
As a Medicare-enrolled provider, Paroly has provided services to 2,792 Medicare beneficiaries, totaling 100,120 services with total Medicare billing of $726,197. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Oceanside, CA
- Active Since 02/21/2007
- Last Updated 07/08/2007
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1306981527
Products in Payments
- KEYTRUDA (Biological) $857.80
- OPDIVO (Biological) $223.75
- ADCETRIS (Biological) $195.79
- BRUKINSA (Drug) $159.86
- Enhertu (Drug) $143.29
- IBRANCE (Drug) $128.51
- LIBTAYO (Drug) $120.41
- Revlimid (Drug) $116.88
- XPOVIO (Drug) $111.30
- ALIMTA (Drug) $107.69
- Rubraca (Drug) $107.22
- Udenyca (Biological) $83.25
- Kyprolis (Biological) $83.15
- OGSIVEO (Drug) $81.95
- SOLIRIS (Drug) $73.21
- TUKYSA (Drug) $70.83
- LONSURF (Drug) $65.11
- SARCLISA (Biological) $63.21
- ZEJULA (Drug) $58.02
- CYRAMZA (Drug) $56.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.